Curated News
By: NewsRamp Editorial Staff
May 01, 2025
United Health Products, Inc. Uplists Shares to OTCQB Venture Market Amid FDA Progress
TLDR
- UHP's uplisting to OTCQB market enhances visibility and liquidity, attracting more investors for potential gains.
- UHP's common shares move from OTC 'Pink' to OTCQB to improve transparency, liquidity, and investor reach.
- UHP's Hemostatic Gauze approval aims to control bleeding, advancing medical technology for better surgical outcomes.
- FDA's regulatory update affects UHP's clinical study progress, highlighting ongoing efforts for innovative medical solutions.
Impact - Why it Matters
This news signifies a positive development for United Health Products, Inc. as it aims to expand its reach and enhance trading liquidity. The company's advancement towards FDA approval for its innovative Hemostatic Gauze could potentially revolutionize the medical technology sector, offering a natural solution for controlling bleeding.
Summary
United Health Products, Inc. has successfully uplisted its common shares from the OTC 'Pink' market to the OTCQB Venture Market. This move is expected to enhance visibility and liquidity for the company as it progresses with its FDA application for Premarket Approval of its CelluSTAT Hemostatic Gauze. UHP CEO Brian Thom views this uplisting as a significant step towards improving corporate transparency and attracting a wider investor base.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, United Health Products, Inc. Uplists Shares to OTCQB Venture Market Amid FDA Progress
